Reference priceEUR €271.77Original source price: INR 24,706.69. Converted estimates are available by currency selection.
| Brand | Cipla Ltd. |
|---|---|
| Manufacturer | Cipla Ltd. |
| Prescription required | Yes |
Plamumab 40mg Injection
Adalimumab (40mg)
Description
Plamumab 40mg Injection contains the active ingredient Adalimumab. It is an antirheumatic agent that belongs to the class of medications called TNF (tumor necrosis factor) inhibitors. It is used alone or with other medications to relieve the symptoms of certain autoimmune disorders. It is used to treat rheumatoid arthritis (a condition in which the body attacks its joints, causing pain, swelling, and loss of function), polyarticular juvenile idiopathic arthritis (a condition that affects children in which the body attacks its own joints, causing pain, swelling, loss of function, and delays in growth and development).Benefits
*Uses of Plamumab 40mg Injection 1.Rheumatoid arthritis 2.Polyarticular juvenile idiopathic arthritis 3.Enthesitis-related arthritis 4.Ankylosing spondylitis 5.Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis 6.Psoriatic arthritis 7.Plaque psoriasis 8.Hidradenitis suppurativa 9.Crohn’s disease 10.Ulcerative colitis 11.Non-infectious uveitisHow to Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.Specification
Your doctor or nurse will give you this medicine. Kindly do not self administer.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them *Common side effects of Plamumab Headache Sinus inflammation Rash Upper respiratory tract infection Injection site reactionDiese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.